- Home
- FLUX vs ANTX Comparison
FLUX vs ANTX Comparison
Compare FLUX & ANTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FLUX
- ANTX
- Stock Information
- Founded
- FLUX N/A
- ANTX 2017
- Country
- FLUX United States
- ANTX United States
- Employees
- FLUX N/A
- ANTX N/A
- Industry
- FLUX Industrial Machinery/Components
- ANTX Biotechnology: Pharmaceutical Preparations
- Sector
- FLUX Miscellaneous
- ANTX Health Care
- Exchange
- FLUX Nasdaq
- ANTX Nasdaq
- Market Cap
- FLUX 25.4M
- ANTX 33.2M
- IPO Year
- FLUX N/A
- ANTX 2022
- Fundamental
- Price
- FLUX $1.88
- ANTX $1.05
- Analyst Decision
- FLUX Strong Buy
- ANTX Buy
- Analyst Count
- FLUX 2
- ANTX 2
- Target Price
- FLUX $6.00
- ANTX $2.00
- AVG Volume (30 Days)
- FLUX 135.9K
- ANTX 257.5K
- Earning Date
- FLUX 08-15-2025
- ANTX 08-12-2025
- Dividend Yield
- FLUX N/A
- ANTX N/A
- EPS Growth
- FLUX N/A
- ANTX N/A
- EPS
- FLUX N/A
- ANTX N/A
- Revenue
- FLUX $63,074,000.00
- ANTX N/A
- Revenue This Year
- FLUX $11.10
- ANTX N/A
- Revenue Next Year
- FLUX $12.66
- ANTX N/A
- P/E Ratio
- FLUX N/A
- ANTX N/A
- Revenue Growth
- FLUX N/A
- ANTX N/A
- 52 Week Low
- FLUX $1.15
- ANTX $0.87
- 52 Week High
- FLUX $4.75
- ANTX $3.07
- Technical
- Relative Strength Index (RSI)
- FLUX 52.47
- ANTX 42.32
- Support Level
- FLUX $1.80
- ANTX $1.05
- Resistance Level
- FLUX $2.53
- ANTX $1.11
- Average True Range (ATR)
- FLUX 0.20
- ANTX 0.04
- MACD
- FLUX 0.02
- ANTX 0.00
- Stochastic Oscillator
- FLUX 35.19
- ANTX 0.00
About FLUX Flux Power Holdings Inc.
Flux Power Holdings Inc design, develop, manufacture, and sell a portfolio of lithium-ion energy storage solutions for electrification of a range of industrial commercial sectors which include material handling, airport ground support equipment (GSE), and other commercial and industrial applications. It offers a high-power battery cell management system(BMS). The company's BMS provides three functions to its battery systems which include Cell Balancing, Monitoring, and Error Reporting.
About ANTX AN2 Therapeutics Inc.
AN2 Therapeutics Inc is a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics derived from its boron chemistry platform. The company has a pipeline of boron-based compounds in development for Chagas disease, non-tuberculous mycobacterial (NTM) and melioidosis, along with early-stage programs focused on targets in infectious diseases and oncology.